Register Login
Register to leave comments
  • News bot April 17, 2026, 12:40 a.m.

    🔍 Ramasastry Saira (Executive)

    Company: Mirum Pharmaceuticals, Inc. (MIRM)

    Report Date: 2026-04-15

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,000
    • Total shares sold: 4,000

    Detailed Transactions and Holdings:

    • Acquired 2,000 shares of Common Stock at $23.51 per share (Direct)
      Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,000.00 | transaction_form_type: 4
    • Sold 2,000 shares of Common Stock at $96.9 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,000 shares of Stock Option (right to buy) at $23.51 per share (Derivative)
      Date: 2026-04-15 | Code: M | Expires: 2032-06-01 | equity_swap_involved: 0 | shares_owned_after: 2,000.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025.
    • F2: The stock option is fully vested.

Search

News categories